Published • loading... • Updated
Alzheimer, Gentile (Eisai): "Early Diagnosis Main Enabler of Innovation" - JIJI PRESSAlzheimer, Gentile (Eisai): "Early Diagnosis Main Enabler of Innovation"
Summary by 時事ドットコム
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
Calabria News+2 Reposted by 2 other sources
(Adnkronos) - Early diagnosis is today the main enabling factor of therapeutic innovation in neurodegenerative diseases. Thus Anna Lisa Gentile, medical affairs manager of Eisai, at the 56th Congress of the Italian Society of Neurology (Sin) that was held in Florence from 24 to 27 October. In the case of Alzheimer's disease we know that [...] L'articolo Alzheimer's, Gentile (Eisai): "Premium diagnosis prime enabler of innovation" comes from Cala…
notizie.itReposted by 
Rec News | Lontani dal mainstream
Rec News | Lontani dal mainstream(Adnkronos) - “Early diagnosis today represents the main enabler of therapeutic innovation in neurodegenerative diseases.” So Anna
Coverage Details
Total News Sources6
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
